Prostate Cancer
📧 Sign up to get email alerts when something new happens for Prostate Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Testing the Safety and Effectiveness of Radiation-based Treatment (Lutetium Lu 177 Dotatate) for Metastatic Prostate Cancer That Has Neuroendocrine Cells [Phase 2]
A Phase 2 clinical trial is evaluating the safety and effectiveness of Lutetium-177 dotatate for metastatic prostate cancer with neuroendocr…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Micro-UltraSound In Cancer - Active Surveillance [NA]
University of Alberta is recruiting for a trial evaluating Micro-UltraSound technology for active surveillance in prostate cancer.
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Urine Prostate Screening Integrated With MRI for Early Detection of Prostate Cancer, UPRISE Trial [NA]
The UPRISE trial is investigating a urine-based screening method combined with MRI for early detection of prostate cancer and is currently n…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: A Study of Comparative Formulations of Niraparib and Abiraterone Acetate (AA) in Men With Prostate Cancer [Phase 1]
This clinical trial update reports an active-not-recruiting Phase 1 study evaluating comparative formulations of Niraparib and Abiraterone A…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: An Efficacy and Safety Study of JNJ-56021927 (Apalutamide) in High-risk Prostate Cancer Subjects Receiving Primary Radiation Therapy: ATLAS [Phase 3]
A Phase 3 clinical trial update for apalutamide (JNJ-56021927) in high-risk prostate cancer patients receiving primary radiation therapy (AT…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Water Vapor Ablation for Localized Intermediate Risk Prostate Cancer [NA]
This clinical trial update describes the water vapor ablation study for localized intermediate-risk prostate cancer and notes that the trial…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: A Study to Assess Adherence to Apalutamide in Metastatic Hormone-Sensitive Prostate Cancer Participants in France
A study assessing adherence to apalutamide in men with metastatic hormone-sensitive prostate cancer in France is currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: A Study of Pasritamig (JNJ-78278343) in Combination With JNJ-86974680 for Treatment of Prostate Cancer [Phase 1]
A Phase 1 clinical trial evaluating Pasritamig (JNJ-78278343) in combination with JNJ-86974680 for prostate cancer is currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Gedatolisib in Combination With Darolutamide in Metastatic Castration-Resistant Prostate Cancer [Phase 1, Phase 2]
Clinical trial update indicates Gedatolisib in combination with Darolutamide is being studied in metastatic castration-resistant prostate ca…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: High-Dose Brachytherapy in Treating Patients With Prostate Cancer [NA]
An ongoing clinical trial evaluating high-dose brachytherapy for prostate cancer across multiple stages; the study is currently active but n…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Multimodal Telerehabilitation of Rural Patients With Advanced Prostate Cancer [NA]
A clinical trial update for multimodal telerehabilitation in rural patients with advanced prostate cancer; the study is currently recruiting…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Posterior Extra-fascial RARP in Intermediate or High Risk Prostate Cancer [NA]
Clinical trial update noting a study on posterior extra-fascial robot-assisted radical prostatectomy for intermediate- to high-risk prostate…
-
CLINICAL_TRIALS research · 2026-04-09Clinical Trial Update: 64Cu-SAR-bisPSMA Positron Emission Tomography: A Phase 3 Study of Participants With Biochemical Recurrence of Prostate Cancer [Phase 3]
A Phase 3 clinical trial evaluating 64Cu-SAR-bisPSMA PET imaging for biochemical recurrence of prostate cancer; the study is currently recru…
-
CLINICAL_TRIALS research · 2026-04-09Clinical Trial Update: [18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate Cancer [NA]
This clinical trial involves PET imaging with [18F]-FDG and [18F] Dihydro-Testosterone to study progressive prostate cancer. The study is cu…
-
CLINICAL_TRIALS research · 2026-04-09Clinical Trial Update: Phase 1 Study of ACE-232 to Treat Patients With Metastatic Castration-Resistant Prostate Cancer [Phase 1]
A Phase 1 study of ACE-232 for metastatic castration-resistant prostate cancer is currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-09Clinical Trial Update: The Effect of Mobile-Based Perioperative Education on Urinary Incontinence and Erectile Function After Radical Prostatectomy [NA]
The clinical trial update indicates that a study evaluating mobile-based perioperative education to improve urinary incontinence and erectil…
-
CLINICAL_TRIALS research · 2026-04-09Clinical Trial Update: A Study to Learn About Real-world Utilization and Outcomes of Darolutamide and Other Androgen Receptor Pathway Inhibitors (ARPIs) for Newly Diagnosed Metastatic Hormone-sensitive Prostate Cancer (de Novo mHSPC) in US Urology Clinics
A real-world observational study in U.S. urology clinics to examine how darolutamide and other androgen receptor pathway inhibitors are used…
-
CLINICAL_TRIALS research · 2026-04-09Clinical Trial Update: Neoadjuvant Dietary Intervention in Intermediate Risk Prostate Cancer [NA]
This document is an update on a neoadjuvant dietary intervention trial for intermediate-risk prostate cancer, currently active but not recru…
-
CLINICAL_TRIALS research · 2026-04-09Clinical Trial Update: Exercise-induced Steroid Changes in Active Surveillance for Prostate Cancer [NA]
A clinical trial studying exercise-induced changes in steroid levels in men with prostate cancer under active surveillance; recruitment has …
-
CLINICAL_TRIALS research · 2026-04-09Clinical Trial Update: Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk Prostate Cancer Prior to Radical Prostatectomy [Phase 3]
Clinical trial update for a Phase 3 study evaluating 64Cu-SAR-bisPSMA PET imaging in high-risk prostate cancer prior to radical prostatectom…
-
CLINICAL_TRIALS research · 2026-04-08Clinical Trial Update: Testing the Addition of the Drug Relugolix to the Usual Radiation Therapy for Advanced-Stage Prostate Cancer, The NRG Promethean Study [Phase 2]
A Phase 2 clinical trial update evaluating the addition of Relugolix to standard radiation therapy for advanced, oligometastatic prostate ca…
-
CLINICAL_TRIALS research · 2026-04-08Clinical Trial Update: Copper Cu 64 PSMA I&T PET Imaging in Men With Newly Diagnosed Prostate Cancer [Phase 3]
Phase 3 trial evaluating Copper-64 PSMA I&T PET imaging for men with newly diagnosed prostate cancer. The study is currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-08Clinical Trial Update: Two Studies for Patients With Unfavorable Intermediate Risk Prostate Cancer Testing Less Intense Treatment for Patients With a Low Gene Risk Score and Testing a More Intense Treatment for Patients With a Higher Gene Risk Score, The Guidance Trial [Phase 3]
Two Phase 3 studies in unfavorable intermediate-risk prostate cancer are evaluating tailored treatment intensity based on a gene risk score.…
-
CLINICAL_TRIALS research · 2026-04-08Clinical Trial Update: Helping Men Adhere to Sexual Rehabilitation Following Prostate Cancer Surgery [NA]
A Memorial Sloan Kettering Cancer Center trial is recruiting to study adherence to sexual rehabilitation after prostate cancer surgery, focu…
-
CLINICAL_TRIALS research · 2026-04-08Clinical Trial Update: Veterans Affairs Seamless Phase II/III Randomized Trial of STAndard Systemic theRapy With or Without PET-directed Local Therapy for Oligometastatic pRosTate Cancer [Phase 2, Phase 3]
VA-sponsored seamless Phase II/III randomized trial evaluating standard systemic therapy with or without PET-directed local therapy for olig…